Metraipolis › archive › dc_0ef35e1d2977
Multiplex pan-filovirus assay performance and reproducibility across varied geographical and resource settings — Europe PMC PMID:42623404
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42623404
- DOI
- 10.1371/journal.pone.0356257
- License (as archived)
- CC0-1.0
- Archived
- 2026-10-06T07:55:19.325Z
- SHA-256 of the archived text
30ce29b859c4384bc512f5d560edf35d6f535d1f226609a8fcc3ab82c336687e- Stable URL of this page
https://metraipolis.com/documento/dc_0ef35e1d2977
How to cite
Multiplex pan-filovirus assay performance and reproducibility across varied geographical and resource settings — Europe PMC PMID:42623404 — Europe PMC (en), https://europepmc.org/article/MED/42623404 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_0ef35e1d2977 (Metraipolis archive dc_0ef35e1d2977, sha256 30ce29b859c4384bc512f5d560edf35d6f535d1f226609a8fcc3ab82c336687e)
BibTeX
@misc{dc0ef35e1d2977,
title = {Multiplex pan-filovirus assay performance and reproducibility across varied geographical and resource settings — Europe PMC PMID:42623404},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42623404},
note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_0ef35e1d2977; sha256 30ce29b859c4384bc512f5d560edf35d6f535d1f226609a8fcc3ab82c336687e},
year = {2026}
}Archived text
Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/42623404. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
Multiplex bead-based immunoassays (MIAs) are promising tools for simultaneously detecting humoral immunity to multiple targets, potentially playing a crucial role in serosurveillance and vaccine response assessments. However, evaluation of assay performance is paramount prior to widespread use. This study presents a performance evaluation of a pan-filovirus MIA through characterization of the analytical range for the EBOV glycoprotein (GP) target and assessments of assay precision and antigen discrimination. The precision of the MIA was evaluated by comparing the detection of anti-filovirus antibodies at two independent laboratory sites: the University of Hawai'i, Honolulu (UH), and the Institut National de Recherche Biomédicale (INRB) in Kinshasa, Democratic Republic of the Congo (DRC). Forty-six samples from Yambuku, DRC, including Ebola virus Disease (EVD) survivors and close contacts, were tested at both sites. Additionally, 907 samples were tested in DRC before and after vaccination with a prophylactic EVD vaccine, ERVEBO. Results demonstrated low variability between laboratories, with intra-assay and inter-laboratory coefficients of variation below predefined thresholds for all filovirus targets included in the multiplex panel. Analyte correlation between sites was high (r2 = 0.86-0.92). Longitudinal analysis detected increased EBOV GP reactivity following vaccination, while reactivity to non-vaccine filovirus antigens remained stable, consistent with minimal cross-reactivity in a vaccinated cohort. These findings suggest that this pan-filovirus MIA produces reproducible results across distinct laboratory settings and may serve as a useful tool for comparative serologic investigations, serosurveillance, and evaluation of EBOV vaccine-associated antibody responses. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera). Pubblicazione: PloS one, 2026 (prima pubblicazione 2026-08-20). Identificativi: PMID 42623404 · PMCID PMC13492765 · DOI 10.1371/journal.pone.0356257. Descrittori MeSH principali: Filoviridae; Hemorrhagic Fever, Ebola; Ebolavirus. Pagina: https://europepmc.org/article/MED/42623404 — https://doi.org/10.1371/journal.pone.0356257. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito). Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0. Letto il 2026-10-06T07:47:50.145Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.